The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2022 1
2021 3
2019 1
2018 5
2017 4
2015 3
2014 3
2013 8
2012 5
2011 2
2010 1

National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. 1

Journal Article 36
Poster 1

GIS Snapshots 1
Infographic 1

1 - 20 of 37 Results

Refine Results

Refine Results:

Prostate cancer : take time to decide

CITE Title : Prostate cancer : take time to decide Corporate Authors(s) : National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. Published Date : 9/13/13 Pages in Document : 1 infographic URL : https://stacks.cdc.gov/view/cdc/24749 National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. (2013). Prostate cancer : take time to decide. National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. "Prostate cancer : take time to decide" (2013) National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. "Prostate cancer : take time to decide" , 2013 Export RIS Citation Information.

:

National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.

9/13/13

:

Most prostate cancers grow slowly, and don’t cause any health problems in men who have them. A PSA test may find a prostate health problem. Treatmen...
Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?☆, ☆☆, ★

CITE Title : Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?☆, ☆☆, ★ Personal Author(s) : Snead, Margaret C.;Kourtis, Athena P.;Melendez, Johan H.;Black, Carolyn M.;Mauck, Christine K.;Penman-Aguilar, Ana;Chaney, Dorothy M.;Gallo, Maria F.;Jamieson, Denise J.;Macaluso, Maurizio;Doncel, Gustavo F.; Published Date : Mar 25 2014 Source : Contraception. 90(2):136-141. URL : https://stacks.cdc.gov/view/cdc/33029 Snead, Margaret C. et al. (2014). Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?☆, ☆☆, ★. 90(2). Snead, Margaret C. et al. "Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?☆, ☆☆, ★" 90, no. 2 (2014) Snead, Margaret C. et al. "Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?☆, ☆☆, ★" vol. 90, no. 2, 2014 Export RIS Citation Information.

:

Snead, Margaret C. ;

Kourtis, Athena P.

Mar 25 2014 | Contraception. 90(2):136-141.

:

ObjectivesThere is currently no information on whether products evaluated in HIV microbicide trials affect the detection of the semen biomarkers prost...
Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies

CITE Title : Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies Personal Author(s) : Lin, Lin;Chan, Cliburn;Hadrup, Sine R.;Froesig, Thomas M.;Wang, Quanli;West, Mike; Published Date : Jun 2013 Source : Stat Appl Genet Mol Biol. 12(3):309-331. URL : https://stacks.cdc.gov/view/cdc/41981 Lin, Lin et al. (2013). Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies. 12(3). Lin, Lin et al. "Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies" 12, no. 3 (2013) Lin, Lin et al. "Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies" vol. 12, no. 3, 2013 Export RIS Citation Information.

:

Lin, Lin ;

Chan, Cliburn

Jun 2013 | Stat Appl Genet Mol Biol. 12(3):309-331.

:

Novel uses of automated flow cytometry technology for measuring levels of protein markers on thousands to millions of cells are promoting increasing n...
Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys

CITE Title : Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys Personal Author(s) : Li, Jun;Ding, Helen;Richards, Thomas B.;Martin, Iman;Kobrin, Sarah;Marcus, Pamela M.; Published Date : 2018 Jul-Aug Source : J Am Board Fam Med. 31(4):658-662. URL : https://stacks.cdc.gov/view/cdc/57792 Li, Jun et al. (2018). Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys. 31(4). Li, Jun et al. "Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys" 31, no. 4 (2018) Li, Jun et al. "Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys" vol. 31, no. 4, 2018 Export RIS Citation Information.

:

Li, Jun ;

Ding, Helen

2018 Jul-Aug | J Am Board Fam Med. 31(4):658-662.

:

PurposesDespite recommendations against prostate cancer screening with prostate-specific antigen (PSA) tests, about one-fourth of men age ≥40 years ...
Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions

CITE Title : Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions Personal Author(s) : Shahangian, Shahram;Sharma, Krishna P.;Fan, Lin;Siegel, David A.; Published Date : 5 02 2021 Source : Cancer Rep (Hoboken). 4(4) URL : https://stacks.cdc.gov/view/cdc/121627 Shahangian, Shahram et al. (2021). Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions. 4(4). Shahangian, Shahram et al. "Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions" 4, no. 4 (2021) Shahangian, Shahram et al. "Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions" vol. 4, no. 4, 2021 Export RIS Citation Information.

:

Shahangian, Shahram ;

Sharma, Krishna P.

5 02 2021 | Cancer Rep (Hoboken). 4(4)

:

BackgroundGiven the public health relevance of PSA‐based screening, various professional organizations have issued recommendations on the use of the...
Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions

CITE Title : Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions Personal Author(s) : Shahangian, Shahram;Fan, Lin;Sharma, Krishna P.;Siegel, David A.; Published Date : 5 01 2021 Source : Cancer Rep (Hoboken). 4(4) URL : https://stacks.cdc.gov/view/cdc/121626 Shahangian, Shahram et al. (2021). Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions. 4(4). Shahangian, Shahram et al. "Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions" 4, no. 4 (2021) Shahangian, Shahram et al. "Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions" vol. 4, no. 4, 2021 Export RIS Citation Information.

:

Shahangian, Shahram ;

Fan, Lin

5 01 2021 | Cancer Rep (Hoboken). 4(4)

:

BackgroundVarious professional organizations have issued recommendations on use of the PSA test to screen for prostate cancer in different age groups....
Assessing Follow-up Care After Prostate-Specific Antigen Elevation in American Indian/Alaska Native Men: A Partnership Approach

CITE Title : Assessing Follow-up Care After Prostate-Specific Antigen Elevation in American Indian/Alaska Native Men: A Partnership Approach Personal Author(s) : Tilburt, Jon C.;James, Katherine M.;Koller, Kathryn;Lanier, Anne P.;Hall, Ingrid J.;Smith, Judith Lee;Ekwueme, Donatus U.;Nicometo, Ann M.;Petersen, Wesley O.; Published Date : 2013 Source : Prog Community Health Partnersh. 7(2):153-161. URL : https://stacks.cdc.gov/view/cdc/34274 Tilburt, Jon C. et al. (2013). Assessing Follow-up Care After Prostate-Specific Antigen Elevation in American Indian/Alaska Native Men: A Partnership Approach. 7(2). Tilburt, Jon C. et al. "Assessing Follow-up Care After Prostate-Specific Antigen Elevation in American Indian/Alaska Native Men: A Partnership Approach" 7, no. 2 (2013) Tilburt, Jon C. et al. "Assessing Follow-up Care After Prostate-Specific Antigen Elevation in American Indian/Alaska Native Men: A Partnership Approach" vol. 7, no. 2, 2013 Export RIS Citation Information.

:

Tilburt, Jon C. ;

James, Katherine M.

2013 | Prog Community Health Partnersh. 7(2):153-161.

:

BackgroundAlthough many studies conducted among American Indian and Alaska Native (AI/AN) populations may help to advance medical science and lead to ...
Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay☆, ☆☆, ★

CITE Title : Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay☆, ☆☆, ★ Personal Author(s) : Snead, Margaret C.;Melendez, Johan H.;Kourtis, Athena P.;Chaney, Dorothy M.;Brown, Teresa M.;Black, Carolyn M.;Mauck, Christine K.;Schwartz, Jill L.;Zenilman, Jonathan M.;Jamieson, Denise J.;Macaluso, Maurizio;Doncel, Gustavo F.; Published Date : Nov 12 2013 Source : Contraception. 89(2):134-138. URL : https://stacks.cdc.gov/view/cdc/34000 Snead, Margaret C. et al. (2013). Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay☆, ☆☆, ★. 89(2). Snead, Margaret C. et al. "Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay☆, ☆☆, ★" 89, no. 2 (2013) Snead, Margaret C. et al. "Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay☆, ☆☆, ★" vol. 89, no. 2, 2013 Export RIS Citation Information.

:

Snead, Margaret C. ;

Melendez, Johan H.

Nov 12 2013 | Contraception. 89(2):134-138.

:

ObjectivesLittle is known about the effects of commonly used lubricants on detection of biomarkers of semen exposure. We investigated the in vitro eff...
Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018

CITE Title : Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018 Personal Author(s) : Richards, Thomas B.;Dai, Shifan;Gray, Simone C.;Hall, Ingrid J.;Siegel, David A.; Published Date : 5 2022;5-2022; Source : Urol Oncol. 40(5):192.e19-192.e25 URL : https://stacks.cdc.gov/view/cdc/117177 Richards, Thomas B. et al. (2022). Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018. 40(5). Richards, Thomas B. et al. "Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018" 40, no. 5 (2022) Richards, Thomas B. et al. "Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018" vol. 40, no. 5, 2022 Export RIS Citation Information.

:

Richards, Thomas B. ;

Dai, Shifan

5 2022 | Urol Oncol. 40(5):192.e19-192.e25

:

Background:Longer intervals between prostate-specific antigen (PSA) tests for routine prostate cancer screening can reduce the harms while maintaining...
Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer

CITE Title : Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer Personal Author(s) : McGarry, Sean D.;Hurrell, Sarah L.;Iczkowski, Kenneth A.;Hall, William;Kaczmarowski, Amy L.;Banerjee, Anjishnu;Keuter, Tucker;Jacobsohn, Kenneth;Bukowy, John D.;Nevalainen, Marja T.;Hohenwalter, Mark D.;See, William A.;LaViolette, Peter S.; Published Date : 8 01 2018 Source : Int J Radiat Oncol Biol Phys. 101(5):1179-1187 URL : https://stacks.cdc.gov/view/cdc/119161 McGarry, Sean D. et al. (2018). Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. 101(5). McGarry, Sean D. et al. "Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer" 101, no. 5 (2018) McGarry, Sean D. et al. "Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer" vol. 101, no. 5, 2018 Export RIS Citation Information.

:

McGarry, Sean D. ;

Hurrell, Sarah L.

8 01 2018 | Int J Radiat Oncol Biol Phys. 101(5):1179-1187

:

Purpose:This study aims to combine multiparametric magnetic resonance imaging (MRI) and digitized pathology with machine learning to generate predicti...
Shared Decision Making in Prostate-Specific Antigen Testing With Men Older Than 70 Years

CITE Title : Shared Decision Making in Prostate-Specific Antigen Testing With Men Older Than 70 Years Personal Author(s) : Li, Jun;Berkowitz, Zahava;Richards, Thomas B.;Richardson, Lisa C.; Published Date : 2013 Jul-Aug Source : J Am Board Fam Med. 26(4):401-408. URL : https://stacks.cdc.gov/view/cdc/31759 Li, Jun et al. (2013). Shared Decision Making in Prostate-Specific Antigen Testing With Men Older Than 70 Years. 26(4). Li, Jun et al. "Shared Decision Making in Prostate-Specific Antigen Testing With Men Older Than 70 Years" 26, no. 4 (2013) Li, Jun et al. "Shared Decision Making in Prostate-Specific Antigen Testing With Men Older Than 70 Years" vol. 26, no. 4, 2013 Export RIS Citation Information.

:

Li, Jun ;

Berkowitz, Zahava

2013 Jul-Aug | J Am Board Fam Med. 26(4):401-408.

:

BackgroundLittle is known about how shared decision making (SDM) is being carried out between older men and their health care providers. Our study aim...
Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi

CITE Title : Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi Personal Author(s) : Zia, Yasaman;Davis, Nicole;Wiener, Jeffrey;Hobbs, Marica M;Lapple, Dana;Chinula, Lameck;Tegha, Gerald;Msika, Albans;Tang, Jennifer;Kourtis, Athena P; Published Date : 2 2021 Source : Sex Transm Infect. 97(1):77 URL : https://stacks.cdc.gov/view/cdc/104998 Zia, Yasaman et al. (2021). Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi. 97(1). Zia, Yasaman et al. "Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi" 97, no. 1 (2021) Zia, Yasaman et al. "Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi" vol. 97, no. 1, 2021 Export RIS Citation Information.

:

Zia, Yasaman ;

Davis, Nicole

2 2021 | Sex Transm Infect. 97(1):77

No Description
Prostate Cancer Screening In Men Ages 75 And Older Fell By 8 Percentage Points After Task Force Recommendation

CITE Title : Prostate Cancer Screening In Men Ages 75 And Older Fell By 8 Percentage Points After Task Force Recommendation Personal Author(s) : Howard, David H.;Tangka, Florence K.;Guy, Gery P.;Ekwueme, Donatus U.;Lipscomb, Joseph; Published Date : Mar 2013 Source : Health Aff (Millwood). 32(3):596-602 URL : https://stacks.cdc.gov/view/cdc/38779 Howard, David H. et al. (2013). Prostate Cancer Screening In Men Ages 75 And Older Fell By 8 Percentage Points After Task Force Recommendation. 32(3). Howard, David H. et al. "Prostate Cancer Screening In Men Ages 75 And Older Fell By 8 Percentage Points After Task Force Recommendation" 32, no. 3 (2013) Howard, David H. et al. "Prostate Cancer Screening In Men Ages 75 And Older Fell By 8 Percentage Points After Task Force Recommendation" vol. 32, no. 3, 2013 Export RIS Citation Information.

:

Howard, David H. ;

Tangka, Florence K.

Mar 2013 | Health Aff (Millwood). 32(3):596-602

:

In 2008 the US Preventive Services Task Force recommended against screening men ages 75 and older for prostate cancer. Using Medicare Current Benefici...
Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening

CITE Title : Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening Personal Author(s) : Li, Jun;Zhao, Guixiang;Hall, Ingrid J.; Published Date : May 18 2015 Source : Am J Prev Med. 49(2):259-263. URL : https://stacks.cdc.gov/view/cdc/32880 Li, Jun et al. (2015). Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening. 49(2). Li, Jun and Zhao, Guixiang and Hall, Ingrid J. "Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening" 49, no. 2 (2015) Li, Jun et al. "Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening" vol. 49, no. 2, 2015 Export RIS Citation Information.

:

Li, Jun ;

Zhao, Guixiang

May 18 2015 | Am J Prev Med. 49(2):259-263.

:

IntroductionFor many men, the net benefit of prostate cancer screening with prostate-specific antigen (PSA) tests may be small. Many major medical org...
Prostate-specific antigen screening: An update of physician beliefs and practices☆, ☆☆,★

CITE Title : Prostate-specific antigen screening: An update of physician beliefs and practices☆, ☆☆,★ Personal Author(s) : Hall, Ingrid J.;Rim, Sun Hee;Massetti, Greta M.;Thomas, Cheryll C.;Li, Jun;Richardson, Lisa C.; Published Date : August 06 2017 Source : Prev Med. 103:66-69 URL : https://stacks.cdc.gov/view/cdc/50595 Hall, Ingrid J. et al. (2017). Prostate-specific antigen screening: An update of physician beliefs and practices☆, ☆☆,★. 103 Hall, Ingrid J. et al. "Prostate-specific antigen screening: An update of physician beliefs and practices☆, ☆☆,★" 103 (2017) Hall, Ingrid J. et al. "Prostate-specific antigen screening: An update of physician beliefs and practices☆, ☆☆,★" vol. 103, 2017 Export RIS Citation Information.

:

Hall, Ingrid J. ;

Rim, Sun Hee

August 06 2017 | Prev Med. 103:66-69

:

PSA testing for early detection of prostate cancer decreased dramatically following the 2012 PSA screening recommendation against routine screening of...
Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis

CITE Title : Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis Personal Author(s) : Li, Jun;Hall, Ingrid J.;Zhao, Guixiang; Published Date : Feb 16 2017 Source : Cancer Causes Control. 28(3):235-240. URL : https://stacks.cdc.gov/view/cdc/57778 Li, Jun et al. (2017). Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis. 28(3). Li, Jun and Hall, Ingrid J. and Zhao, Guixiang "Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis" 28, no. 3 (2017) Li, Jun et al. "Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis" vol. 28, no. 3, 2017 Export RIS Citation Information.

:

Li, Jun ;

Hall, Ingrid J.

Feb 16 2017 | Cancer Causes Control. 28(3):235-240.

:

IntroductionGiven the discordant prostate cancer screening recommendations in the United States, shared decision-making (SDM) has become increasingly ...
Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA

CITE Title : Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA Personal Author(s) : Jamshidi, Roxanne;Penman-Aguilar, Ana;Wiener, Jeffrey;Gallo, Maria F.;Zenilman, Jonathan M.;Melendez, J.H.;Snead, Margaret;Black, Carolyn M.;Jamieson, Denise J.;Macaluso, Maurizio; Published Date : Aug 14 2013 Source : Contraception. 88(6):749-757. URL : https://stacks.cdc.gov/view/cdc/52446 Jamshidi, Roxanne et al. (2013). Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA. 88(6). Jamshidi, Roxanne et al. "Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA" 88, no. 6 (2013) Jamshidi, Roxanne et al. "Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA" vol. 88, no. 6, 2013 Export RIS Citation Information.

:

Jamshidi, Roxanne ;

Penman-Aguilar, Ana

Aug 14 2013 | Contraception. 88(6):749-757.

:

BackgroundAlthough biological markers of women’s exposure to semen from vaginal intercourse have been developed as surrogates for risk of infection ...
A simple schema for informed decision-making about prostate cancer screening

CITE Title : A simple schema for informed decision-making about prostate cancer screening Personal Author(s) : Vickers, Andrew J.;Edwards, Kelly;Cooperberg, Matthew R.;Mushlin, Alvin I.; Published Date : Sep 16 2014 Source : Ann Intern Med. 161(6):441-442. URL : https://stacks.cdc.gov/view/cdc/30662 Vickers, Andrew J. et al. (2014). A simple schema for informed decision-making about prostate cancer screening. 161(6). Vickers, Andrew J. et al. "A simple schema for informed decision-making about prostate cancer screening" 161, no. 6 (2014) Vickers, Andrew J. et al. "A simple schema for informed decision-making about prostate cancer screening" vol. 161, no. 6, 2014 Export RIS Citation Information.

:

Vickers, Andrew J. ;

Edwards, Kelly

Sep 16 2014 | Ann Intern Med. 161(6):441-442.

No Description
Exploring Discordance Between Biologic and Self-Reported Measures of Semen Exposure: A Qualitative Study Among Female Patients Attending an STI Clinic in Jamaica

CITE Title : Exploring Discordance Between Biologic and Self-Reported Measures of Semen Exposure: A Qualitative Study Among Female Patients Attending an STI Clinic in Jamaica Personal Author(s) : Carter, Marion W.;Bailey, Althea;Snead, Margaret C.;Costenbader, Elizabeth;Townsend, Malene;Macaluso, Maurizio;Jamieson, Denise J.;Hylton-Kong, Tina;Warner, Lee;Steiner, Markus J.; Published Date : 2 2013;2-2013; Source : AIDS Behav. 17(2):728-736 URL : https://stacks.cdc.gov/view/cdc/33019 Carter, Marion W. et al. (2013). Exploring Discordance Between Biologic and Self-Reported Measures of Semen Exposure: A Qualitative Study Among Female Patients Attending an STI Clinic in Jamaica. 17(2). Carter, Marion W. et al. "Exploring Discordance Between Biologic and Self-Reported Measures of Semen Exposure: A Qualitative Study Among Female Patients Attending an STI Clinic in Jamaica" 17, no. 2 (2013) Carter, Marion W. et al. "Exploring Discordance Between Biologic and Self-Reported Measures of Semen Exposure: A Qualitative Study Among Female Patients Attending an STI Clinic in Jamaica" vol. 17, no. 2, 2013 Export RIS Citation Information.

:

Carter, Marion W. ;

Bailey, Althea

2 2013 | AIDS Behav. 17(2):728-736

:

We explored the use of qualitative interviews to discuss discrepancies between two sources of information on unprotected sex: biomarker results and se...
The Use of Biomarkers of Semen Exposure in Sexual and Reproductive Health Studies

CITE Title : The Use of Biomarkers of Semen Exposure in Sexual and Reproductive Health Studies Personal Author(s) : Snead, Margaret Christine;Black, Carolyn M.;Kourtis, Athena P.; Published Date : September 30 2014 Source : J Womens Health (Larchmt). 23(10):787-791 URL : https://stacks.cdc.gov/view/cdc/30220 Snead, Margaret Christine et al. (2014). The Use of Biomarkers of Semen Exposure in Sexual and Reproductive Health Studies. 23(10). Snead, Margaret Christine and Black, Carolyn M. and Kourtis, Athena P. "The Use of Biomarkers of Semen Exposure in Sexual and Reproductive Health Studies" 23, no. 10 (2014) Snead, Margaret Christine et al. "The Use of Biomarkers of Semen Exposure in Sexual and Reproductive Health Studies" vol. 23, no. 10, 2014 Export RIS Citation Information.

:

Snead, Margaret Christine ;

Black, Carolyn M.

September 30 2014 | J Womens Health (Larchmt). 23(10):787-791

:

Biomarkers of semen exposure have been used in studies investigating the safety and efficacy of barrier methods of contraception. They have been used ...

1 - 20 / 37

1 2